QuidelOrtho Corp Earnings Per Share Disclosure
| Fiscal Year Ended | |||||||||||||||||
| (In millions) | 2025 | 2024 | 2023 | ||||||||||||||
| Basic weighted-average shares of common stock outstanding | 67.8 | 67.2 | 66.8 | ||||||||||||||
Dilutive potential shares issuable from stock options and RSUs (1) | — | — | — | ||||||||||||||
| Diluted weighted-average shares of common stock outstanding | 67.8 | 67.2 | 66.8 | ||||||||||||||
| Fiscal Year Ended | |||||||||||||||||
| (In millions) | 2025 | 2024 | 2023 | ||||||||||||||
| Basic weighted-average shares of common stock outstanding | 67.8 | 67.2 | 66.8 | ||||||||||||||
| Dilutive potential shares issuable from stock options and RSUs | 0.2 | 0.2 | 0.5 | ||||||||||||||
| Diluted weighted-average shares of common stock outstanding | 68.0 | 67.4 | 67.3 | ||||||||||||||
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Feb 19, 2026 | Showing above |
| 2024 | Feb 27, 2025 | |
| 2023 | Feb 29, 2024 | |
About Earnings Per Share Disclosures
The earnings per share disclosure breaks down the calculation from net income to both basic and diluted EPS, revealing the full impact of a company's capital structure on per-share economics. The reconciliation between basic and diluted share counts exposes how many stock options, RSUs, convertible securities, and warrants are potentially dilutive to existing shareholders.
Key signals: a widening gap between basic and diluted shares indicates growing dilution from equity compensation or convertible instruments. Anti-dilutive securities excluded from the diluted calculation deserve attention — they represent latent dilution that will materialize if the stock price rises. Watch for the effect of share buybacks on per-share metrics: EPS growth driven primarily by repurchases rather than income growth signals weakening fundamentals. Compare year-over-year changes in the diluted share count against equity compensation expense to assess whether management is effectively managing dilution.